These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3787007)

  • 21. [Evaluation of the clinical usefulness of molsidomine in ischemic heart disease].
    Janicki K; Ochmański W; Kmieć M
    Pol Tyg Lek; 1986 Jun 23-30; 41(25-26):829-34. PubMed ID: 3534821
    [No Abstract]   [Full Text] [Related]  

  • 22. Detrimental effects of acute heparin administration on ischemic threshold in patients with coronary artery disease.
    Fragasso G; Leonardo F; Piatti P; Monti LD; Sheiban I; Gernone F; Setola E; Pontiroli AE; Chierchia SL
    Ital Heart J; 2000 Jun; 1(6):407-11. PubMed ID: 10929741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Problems in long-term therapy of coronary heart disease: pharmacotherapy].
    Gilfrich HJ
    Med Klin (Munich); 1987 Jan; 1():29-32. PubMed ID: 3106752
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term efficacy of amlodipine in patients with severe coronary artery disease.
    Navarro Estrada JL; Oliveri R
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S24-8. PubMed ID: 7522284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemodynamic and coronary effects of molsidomine in patients with stable coronary insufficiency in the basal state, during an atrial stimulation test and a cold test].
    Gourgon R; Neukirch F; Zygelman M; Michel PL; Mérillon JP; Pansard Y; Squara P; Laurent S; Dahan M; Juliard JM
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):529-34. PubMed ID: 6689395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biorhythm influence on the course of ischemic heart disease during combined treatment with molsidomine and anaprilin].
    Vakaliuk IP
    Ter Arkh; 1986; 58(12):49-50. PubMed ID: 3824212
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertension.
    Böger RH; Mügge A; Bode-Böger SM; Heinzel D; Höper MM; Frölich JC
    Int J Clin Pharmacol Ther; 1996 Aug; 34(8):323-8. PubMed ID: 8864793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemodynamic effects of molsidomine.
    Rakovec P
    J Cardiovasc Pharmacol; 1980; 2(6):893-4. PubMed ID: 6160337
    [No Abstract]   [Full Text] [Related]  

  • 30. Preload or afterload reduction: which is more beneficial for patients with ischemic heart disease?
    Caralis DG; Kyriakides Z
    Cardiovasc Drugs Ther; 1988 May; 2(1):79-82. PubMed ID: 3154698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of nifedipine on pulmonary artery pressure in patients with coronary disease].
    Wolf R; Witt E; Hochrein H
    Med Welt; 1976 Oct; 27(43):2079-82. PubMed ID: 994820
    [No Abstract]   [Full Text] [Related]  

  • 32. [Molsidomine in the treatment of ischemic heart disease].
    Sterkowicz S
    Wiad Lek; 1987 Oct; 40(20):1389-95. PubMed ID: 3328427
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of verapamil on the cycloergometric test in patients with coronary artery disease (complementary study)].
    Martins de Oliveira J
    Arq Bras Cardiol; 1979 Feb; 32(2):135-7. PubMed ID: 464855
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute hemodynamic effects of molsidomine in patients with ischemic cardiomyopathy.
    Caralis DG; Kyriakides Z; Ioakimides C
    Cardiovasc Drugs Ther; 1991 Feb; 5(1):155-6. PubMed ID: 2036334
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical use of molsidomine in the treatment of patients with coronary artery diseases].
    Dukát A
    Bratisl Lek Listy; 1996 Aug; 97(8):490-2. PubMed ID: 8963702
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardioprotection by molsidomine and iloprost in myocardial ischemia in anaesthetized cats.
    Gryglewski RJ; Swies J
    Agents Actions Suppl; 1992; 37():265-72. PubMed ID: 1378687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pulmonary circulation in ischemic heart diseases under bicycle ergometer load and acute strophanthin test conditions (based on data from catheterization of the right heart and pulmonary artery)].
    Ol'binskaia LL; Savchenko AP; Iankin VV
    Kardiologiia; 1976 Oct; 16(10):71-6. PubMed ID: 1018432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacology of molsidomine and its active metabolites].
    Böhme E
    Med Klin (Munich); 1990 Feb; 85 Suppl 1():7-10. PubMed ID: 2159105
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of sidnofarm in the treatment of pulmonary-cardiac insufficiency].
    Zharov EI; Butorov IV; Bodrug NI
    Klin Med (Mosk); 1988 Jul; 66(7):36-8. PubMed ID: 3184824
    [No Abstract]   [Full Text] [Related]  

  • 40. [The placebo phenomenon and its significance in coronary disease].
    Janicki AG
    Pol Tyg Lek; 1987 Dec 21-28; 42(51-52):1632-6. PubMed ID: 3330796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.